Guangdong Hengrui Pharmaceutical Co., Ltd

This study tests an experimental injection called SHR-3045 in 30 adults with moderate to severe rheumatoid arthritis. The goal is to see if it reduces joint pain and swelling better than a placebo. Participants will receive either the drug or a dummy shot, and doctors will track …

This study tests an experimental drug called SHR-1819 for people with moderate to severe atopic dermatitis (eczema). About 652 adults will receive either the drug or a placebo to see if it improves skin symptoms and reduces itching. The main goal is to measure skin clearing and i…

This early-phase study tests a new drug called SHR-4712 in 15 adults with advanced solid tumors that have not responded to other treatments. The main goals are to check the drug's safety and how the body processes it. Participants receive the drug until their disease worsens or s…

This early-stage study involves 160 healthy adults aged 18–55 to see how well the body absorbs an experimental drug (SHR-1819) when given through different injection devices. The drug is being developed for atopic dermatitis (eczema), but this trial does not treat the condition—i…